title: Characterization of a novel angiogenic model based on stable, fluorescently labelled endothelial cell lines amenable to scale-up for high content screening.
abstract: BACKGROUND
  Blood vessel formation is important for many physiological and pathological processes and is therefore a critical target for drug development. Inhibiting angiogenesis to starve a tumour or promoting 'normalization' of tumour vasculature in order to facilitate delivery of anticancer drugs are both areas of active research. Recapitulation of vessel formation by human cells in vitro allows the investigation of cell-cell and cell-matrix interactions in a controlled environment and is therefore a crucial step in developing HCS (high content screening) and HTS (high throughput screening) assays to search for modulators of blood vessel formation. HUVECs (human umbilical-vein endothelial cells) exemplify primary cells used in angiogenesis assays. However, primary cells have significant limitations that include phenotypic decay and/or senescence by six to eight passages in culture, making stable integration of fluorescent markers and large-scale expansion for HTS problematic. To overcome these limitations for HTS, we developed a novel angiogenic model system that employs stable fluorescent endothelial cell lines based on immortalized HMECs (human microvascular endothelial cell). We then evaluated HMEC cultures, both alone and co-cultured with an EMC (epicardial mesothelial cell) line that contributes vascular smooth muscle cells, to determine the suitability for HTS or HCS.
  
  
  RESULTS
  The endothelial and epicardial lines were engineered to express a panel of nuclear- and cytoplasm-localized fluorescent proteins to be mixed and matched to suit particular experimental goals. HMECs retained their angiogenic potential and stably expressed fluorescent proteins for at least 13 passages after transduction. Within 8 h after plating on Matrigel, the cells migrated and coalesced into networks of vessel-like structures. If co-cultured with EMCs, the branches formed cylindrical-shaped structures of HMECs surrounded by EMC derivatives reminiscent of vessels. Network formation measurements revealed responsiveness to media composition and control compounds.
  
  
  CONCLUSIONS
  HMEC-based lines retain most of the angiogenic features of primary endothelial cells and yet possess long-term stability and ease of culture, making them intriguing candidates for large-scale primary HCS and HTS (of ~10000-1000000 molecules). Furthermore, inclusion of EMCs demonstrates the feasibility of using epicardial-derived cells, which normally contribute to smooth muscle, to model large vessel formation. In summary, the immortalized fluorescent HMEC and EMC lines and straightforward culture conditions will enable assay development for HCS of angiogenesis.
authors: Sanford-Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, CA 92037, USA. nataliep@sanfordburnham.org
authors: Natalie L
authors: NL
authors: Prigozhina
authors: Andrew
authors: A
authors: Heisel
authors: Ke
authors: K
authors: Wei
authors: Roberta
authors: R
authors: Noberini
authors: Edward A
authors: EA
authors: Hunter
authors: Diego
authors: D
authors: Calzolari
authors: Jordan R
authors: JR
authors: Seldeen
authors: Elena B
authors: EB
authors: Pasquale
authors: Pilar
authors: P
authors: Ruiz-Lozano
authors: Mark
authors: M
authors: Mercola
authors: Jeffrey H
authors: JH
authors: Price
mesh_terms: D001681:Biological Assay; D002450:Cell Communication; D002460:Cell Line; D060833:Cellular Microenvironment; D018920:Coculture Techniques; D005456:Fluorescent Dyes; D061307:Human Umbilical Vein Endothelial Cells / Q000166:cytology / Q000502:physiology; D006801:Humans; D008955:Models, Cardiovascular; D032389:Myocytes, Smooth Muscle / Q000166:cytology; D009389:Neovascularization, Pathologic; D018919:Neovascularization, Physiologic; D010496:Pericardium / Q000166:cytology; D012680:Sensitivity and Specificity
chemical_list: D005456:Fluorescent Dyes